1. Home
  2. PMM vs SMTI Comparison

PMM vs SMTI Comparison

Compare PMM & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Putnam Managed Municipal Income Trust

PMM

Putnam Managed Municipal Income Trust

N/A

Current Price

$5.94

Market Cap

269.4M

Sector

Finance

ML Signal

N/A

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

N/A

Current Price

$34.92

Market Cap

313.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PMM
SMTI
Founded
1989
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
269.4M
313.5M
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
PMM
SMTI
Price
$5.94
$34.92
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$34.00
AVG Volume (30 Days)
76.3K
325.8K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
4.68%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
N/A
$12.48
P/E Ratio
$27.43
N/A
Revenue Growth
N/A
32.47
52 Week Low
$5.91
$16.05
52 Week High
$6.60
$35.70

Technical Indicators

Market Signals
Indicator
PMM
SMTI
Relative Strength Index (RSI) 19.02 78.05
Support Level $5.91 $33.99
Resistance Level $6.35 N/A
Average True Range (ATR) 0.06 0.26
MACD -0.02 -0.26
Stochastic Oscillator 3.84 93.10

Price Performance

Historical Comparison
PMM
SMTI

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: